Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything

Eli Lilly stock rises on FDA fast-track hopes for its oral GLP-1 obesity drug and $27B U.S. manufacturing expansion; it's a tough trade but solid long-term hold

MarketBeat

Novo Nordisk shares climb after positive anti-obesity pill results

Danish drugmaker jumps by about £9bn as trial shows ‘significant weight loss’ with tablet version of Wegovy

The Guardian - UK

New type of jab helps to maintain weight loss

Experts have developed a new drug which helps tackle the underlying causes of obesity.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Vital breakthrough as once-a-day pill can help people lose ‘significant’ weight

A fifth of people taking the weight-loss tablet Orforglipron lost 20 per cent of their body weight

The Independent UK

Abolishing daylight saving time could slash these life-threatening health conditions

‘We found that staying in standard time or staying in daylight saving time is definitely better than switching twice a year’

The Independent UK

FDA takes aim at Hims and other telehealth services in drug advertising blitz

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy

The Independent UK

Doctors uncover genetic clues as to why obesity affects people differently

A large-scale study compared body fat levels with markers of metabolic health, such as blood pressure, cholesterol and blood sugar.

Euronews

Read news from The Economist, FT, and more,
with one subscription

Weight loss drugs like Ozempic work well for kids and teens, study finds. But should kids take them?

Euronews

Obese children as young as six could benefit from weight-loss jabs

About a third of children leaving primary school are overweight or living with obesity in England

The Independent UK

How are overweight and obesity affecting EU citizens?

Overweight and obesity are rapidly increasing across Europe, a new study has found. In several Eastern European countries, three-quarters of men are overweight or obese.

Euronews

Attack on obesity or cash grab? Tax hike on sugary drinks divides opinion in Mexico

Mexicans, who consume on average 166 litres of fizzy drinks a year, will face a near doubling of the tax rate

The Guardian - US

A life-changing journey powered by wheels of cheese

There already exists a cure for ennui, and it’s found in the pub. But when former BBC producer and Canadian radio presenter Michael Finnerty — famous enough over there to have his face on billboards — finds his life without lustre, he does not turn to booze, which shows a…

Evening Standard

More than half of UK births now involve medical intervention, audit finds

Caesareans drive rise in assisted deliveries as experts warn of complex pregnancies linked to age, obesity and other conditions

The Guardian - UK

More of the world's children are obese than underweight, UN warns

For the first time, more school-aged children are obese than underweight around the world, with the exception of sub-Saharan Africa and South Asia. The warning came in a report released on Wednesday by the United Nations children’s agency Unicef.

Radio France Internationale

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative clinical effectiveness and value of Novo Nordisk A/S’ (NYSE:NVO) semaglutide (Wegovy) and Eli Lilly and Co.’s (NYSE:LLY) tirzepatide (Zepbound) for obesity management.

Euronews

Novo Nordisk to cut 9,000 jobs as Eli Lilly competition intensifies

The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity drug market.

Euronews

More children are obese than underweight in world-first, UNICEF warns

About one in 10 children globally is obese, the UN agency said.

The Independent UK

More children now obese than underweight for first time ever

Major study by Unicef finds 391 million children across the globe now overweight or obese

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Guardian - UK

Junk food leads to more children being obese than underweight for first time

Cheap ultra-processed food behind rise in overweight children, with one in 10 now obese globally, says Unicef

MarketBeat

3 Under-the-Radar Biotechs Under $5 That Could Soar 200%

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.

Euronews

Study: Weight fluctuations may accelerate cognitive decline in the elderly

According to researchers in the Department of Nutritional Sciences at Pennsylvania State University, adults over the age of 65 who experience weight loss or fluctuations of more than 5% may suffer from faster cognitive decline.

The Independent UK

New weight-loss pill could reach UK by next year, says Mounjaro boss

Eli Lilly’s new pill could offer an easier path to weight loss for needle-averse patients

The Guardian - UK

Dining across the divide: ‘The one thing we bonded over was despising Reform’

A medical charity worker and an oncologist delved into the NHS, obesity and assisted dying. But could they agree on hiring doctors from abroad?

The Independent UK

Weight-loss jabs are not enough to tackle the obesity crisis, experts warn

THE UK’S OBESITY CHALLENGE : Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and Alicja Hagopian that weight-loss jabs alone will not be enough to solve the obesity crisis

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.